...
首页> 外文期刊>Journal of clinical neuroscience: official journal of the Neurosurgical Society of Australasia >Cerebrospinal fluid spectrophotometry of bilirubin, not the Xanthochromic Index, for the detection of CT-negative sub-arachnoid haemorrhage.
【24h】

Cerebrospinal fluid spectrophotometry of bilirubin, not the Xanthochromic Index, for the detection of CT-negative sub-arachnoid haemorrhage.

机译:脑脊液分光光度法测定胆汁中CT阴性的蛛网膜下腔出血,而不是黄变指数。

获取原文
获取原文并翻译 | 示例
           

摘要

The paper by Wood et al.1 addresses a very important topic: what is the predictive value of cerebrospinal fluid (CSF) spectrophotometry in detecting CT-negative sub-arachnoid haemorrhage? Unfortunately the study is fundamentally flawed. Despite identifying that bilirubin is detected by spectrophotometry the authors use a 'Xanthochromic Index' that is based on measurement of the Soret band of oxyhaemoglobm at 415 nm. The Index was derived over 45 years ago and only takes account of bilirubin if the Index is >0.080. They refer to our work,3 criticising it for complicating matters, a charge we refute; and they fail to recognise that we emphasise the relevance of bilirubin measurement at the expense of haemoglobin and methaemoglobin, nor do they recognise that oxyhaemoglobm with an absorbance >0.1 can mask bilirubin, as traumatic taps are not always readily identifiable; this could easily lead to false negatives. Our guidelines were based on 740 scans with known outcome. It is possible from our figures to estimate the likelihood of detecting or missing an aneurysm. Our criteria for a positive bilirubin are based on those of Chalmers4 which allow for small but clinically significant increases to be detected.
机译:Wood等人的论文1解决了一个非常重要的主题:脑脊液(CSF)分光光度法对CT阴性的蛛网膜下腔出血的预测价值是什么?不幸的是,这项研究存在根本缺陷。尽管鉴定出通过分光光度法可检测到胆红素,但作者仍使用基于基于415 nm氧合血红蛋白Soret带测量值的“黄变指数”。该指数来自45年前,如果指数> 0.080,则仅考虑胆红素。他们提到我们的工作,3批评它使事情复杂化,我们驳斥了这一指控;他们没有认识到我们强调以血红蛋白和血红蛋白为代价来强调胆红素的相关性,也没有认识到吸光度大于0.1的羟化血红蛋白可以掩盖胆红素,因为创伤性水龙头并不总是很容易辨认;这很容易导致假阴性。我们的指南基于740项已知结果的扫描。从我们的数字可以估计出发现或缺失动脉瘤的可能性。我们的胆红素阳性标准基于Chalmers4的标准,可以检测到微小但临床上显着的增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号